Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;149(6):1056e-1061e.
doi: 10.1097/PRS.0000000000009088. Epub 2022 Mar 29.

Understanding Breast Implant-Associated Illness: A Delphi Survey Defining Most Frequently Associated Symptoms

Claire E E de Vries  1 , Manraj N Kaur  1 , Anne F Klassen  1 , Katie Sommers  1 , Keith M Hume  1 , Andrea L Pusic  1
Affiliations

Understanding Breast Implant-Associated Illness: A Delphi Survey Defining Most Frequently Associated Symptoms

Claire E E de Vries et al. Plast Reconstr Surg. .

Abstract

Background: Increased understanding of the constellation of symptoms referred to as breast implant illness is necessary to better address patient concerns, provide evidence-based care, and inform prospective patients about potential risks. The aim of this study was to reach consensus on the symptoms most frequently associated with breast implant illness, which will subsequently inform the development of a symptom severity scale.

Methods: A literature search of peer-reviewed and gray literature was performed to identify a comprehensive list of symptoms associated with breast implant illness. This was followed by an online, three-round, modified Delphi survey where the list of symptoms was reviewed by an international panel to determine the top 20, 10, and five symptoms associated with breast implant illness. A virtual meeting of panelists was held to reach consensus on the symptoms to be included in a symptom severity scale.

Results: A total of 44 symptoms were identified through the literature search. The modified Delphi survey panel consisted of patient research partners [n = 9 (34.6 percent)], plastic surgeons [n = 10 (38.5 percent)], researchers [n = 6 (23.1 percent)], and a member of the U.S. Food and Drug Administration [n = 1 (3.8 percent)]. The response rates of round 1, 2, and 3 were 85, 96, and 100 percent, respectively. Consensus was reached on the top 19 and top six symptoms to be included in long and short forms of a symptom severity scale.

Conclusions: There was a high level of agreement on the symptoms to be included in a symptom severity scale. The next steps include conducting in-depth qualitative interviews with women with these symptoms and breast implants to understand the experience and impact of these symptoms and develop the preliminary scale.

PubMed Disclaimer

References

    1. American Society of Plastic Surgeons. 2019 Plastic surgery statistics report. Available at: https://www.plasticsurgery.org/news/plastic-surgery-statistics?sub=2019+... . Accessed August 28, 2020.
    1. Spear SL, Parikh PM, Goldstein JA. History of breast implants and the Food and Drug Administration. Clin Plast Surg. 2009;36:15–21, v.
    1. Deva AK, Cuss A, Magnusson M, Cooter R. The “game of implants”: A perspective on the crisis-prone history of breast implants. Aesthet Surg J. 2019;39(Suppl 1):S55–S65.
    1. Breiting VB, Hölmich LR, Brandt B, et al. Long-term health status of Danish women with silicone breast implants. Plast Reconstr Surg. 2004;114:217–226; discussion 227–228.
    1. Lipworth L, Holmich LR, McLaughlin JK. Silicone breast implants and connective tissue disease: No association. Semin Immunopathol. 2011;33:287–294.